Kivu Ebola epidemic

From WikiMD's WELLNESSPEDIA

Kivu Ebola epidemic is an outbreak of the Ebola virus disease that occurred in the eastern part of the Democratic Republic of the Congo (DRC). The epidemic began in August 2018 and was declared over in June 2020. It is the second-largest Ebola outbreak in history, after the 2014–2016 West Africa Ebola outbreak.

Background[edit]

The Kivu Ebola epidemic began in the Kivu and Ituri provinces of the DRC. These areas are characterized by conflict and displacement, which complicated efforts to control the outbreak. The World Health Organization (WHO) declared the outbreak a Public Health Emergency of International Concern in July 2019.

Epidemiology[edit]

The Kivu Ebola epidemic resulted in 3,481 confirmed cases and 2,299 deaths, with a case fatality rate of 66%. The majority of cases were reported in the provinces of Kivu and Ituri. The epidemic was particularly severe in the city of Beni, which accounted for nearly a third of all cases.

Response[edit]

The response to the Kivu Ebola epidemic was coordinated by the DRC's Ministry of Health, with support from the WHO and other international partners. The response included vaccination, contact tracing, and infection prevention and control measures. However, the response was hampered by ongoing conflict in the region, as well as community mistrust and resistance.

Impact[edit]

The Kivu Ebola epidemic had a significant impact on the affected communities, causing widespread fear and disruption. The epidemic also strained the DRC's health system, which was already dealing with multiple other health crises, including measles and malaria outbreaks.

See also[edit]


Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Kivu_Ebola_epidemic&oldid=6336673"